Performance of BCRAT in high-risk patients with breast cancer - Authors' reply

Affiliations

¹ Department of Epidemiology, Mailman School of Public Health Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA. Electronic address: mt146@columbia.edu.
² Department of Epidemiology, Mailman School of Public Health Columbia University, New York, NY 10032, USA.
³ Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, VIC, Australia.

Comment

Mary Beth Terry et al. Lancet Oncol. 2019 Jun.

. 2019 Jun;20(6):e286.

doi: 10.1016/S1470-2045(19)30311-0.

¹ Department of Epidemiology, Mailman School of Public Health Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA. Electronic address: mt146@columbia.edu.
² Department of Epidemiology, Mailman School of Public Health Columbia University, New York, NY 10032, USA.
³ Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, VIC, Australia.

No abstract available

Comment on

10-year performance of four models of breast cancer risk: a validation study.
Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S, Andrulis IL, John EM, Phillips KA, Daly MB, Buys SS, Hopper JL, MacInnis RJ. Terry MB, et al. Lancet Oncol. 2019 Apr;20(4):504-517. doi: 10.1016/S1470-2045(18)30902-1. Epub 2019 Feb 21. Lancet Oncol. 2019. PMID: 30799262
Performance of BCRAT in high-risk patients with breast cancer.
Gail MH. Gail MH. Lancet Oncol. 2019 Jun;20(6):e285. doi: 10.1016/S1470-2045(19)30301-8. Lancet Oncol. 2019. PMID: 31162092 Free PMC article. No abstract available.